A drug which appears to reverse Huntington’s disease is being trialled in humans after proving successful in monkeys and mice.

The new drug, called IONIS-HTTRx, silences the gene known to be responsible for the production of a protein which causes Huntington’s.

The disease is a hereditary condition which damages nerve cells in the brain and effects around 7,000 people in Britain. It causes uncontrolled movements, loss of intellectual abilities, emotional problems and eventually death.

More at Source: First drug to reverse Huntington’s disease begins human trials – Telegraph